21.50Open21.50Pre Close0 Volume3 Open Interest85.00Strike Price0.00Turnover78.51%IV-2.38%PremiumJan 17, 2025Expiry Date24.10Intrinsic Value100Multiplier21DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9225Delta0.0070Gamma4.35Leverage Ratio-0.0788Theta0.0443Rho4.01Eff Leverage0.0383Vega
Altair Engineering Stock Discussion
$Altair Engineering (ALTR.US)$
• $Carvana (CVNA.US)$ : Raymond James Upgrades to Market Perform from Underperform
• $Newmont (NEM.US)$ : Canaccord Upgrades to Buy from Hold - PT $66 (from $60)
• $NiSource (NI.US)$ : Edward Jones Upgrades to Buy from Hold
• $Schlumberger (SLB.US)$ : Benchmark Upgrades to Buy from Hold - PT $55
Downgrades
• $Agilysys (AGYS.US)$ : Craig-Hallum Downgrades to Hold from Buy
• $Cleveland-Cliffs (CLF.US)$ : GLJ Research Downgrades t...
• $Axsome Therapeutics (AXSM.US)$ +39.1% (received from FDA proposed labeling for the its AXS-05 product candidate with respect to its New Drug Application for AXS-05 for the treatment of major depressive disorder)
• $Capricor Therapeutics (CAPR.US)$ +4% (announces statistically significant clinical benefits in skeletal muscle function in non-ambulant duchenne muscular dystrophy patients treated with CAP-1002 in HOPE-2 Open L...
No comment yet